Document is current
Any future updates will be listed below
-
Authors
Deota, Shaunak https://orcid.org/0000-0002-4862-7414
Pendergast, Julie S.
Kolthur-Seetharam, Ullas https://orcid.org/0000-0003-2612-1743
Esser, Karyn A. https://orcid.org/0000-0002-5791-1441
Gachon, Frédéric https://orcid.org/0000-0002-9279-9707
Asher, Gad https://orcid.org/0000-0001-9403-7856
Dibner, Charna https://orcid.org/0000-0002-4188-803X
Benitah, Salvador Aznar https://orcid.org/0000-0002-9059-5049
Escobar, Carolina https://orcid.org/0000-0002-2974-7875
Muoio, Deborah M. https://orcid.org/0000-0003-3760-9277
Zhang, Eric Erquan https://orcid.org/0000-0002-4472-7493
Hotamışlıgil, Gökhan S. https://orcid.org/0000-0003-2906-1897
Bass, Joseph
Takahashi, Joseph S. https://orcid.org/0000-0003-0384-8878
Rabinowitz, Joshua D. https://orcid.org/0000-0002-1247-4727
Lamia, Katja A. https://orcid.org/0000-0001-9533-0499
de Cabo, Rafael
Kajimura, Shingo https://orcid.org/0000-0003-0672-5910
Longo, Valter D. https://orcid.org/0000-0002-0946-7534
Xu, Ying https://orcid.org/0000-0002-6689-7768
Lazar, Mitchell A. https://orcid.org/0000-0001-8653-1280
Verdin, Eric https://orcid.org/0000-0003-3703-3183
Zierath, Juleen R. https://orcid.org/0000-0001-6891-7497
Auwerx, Johan https://orcid.org/0000-0002-5065-5393
Drucker, Daniel J. https://orcid.org/0000-0001-6688-8127
Panda, Satchidananda https://orcid.org/0000-0002-7855-0091
- License Information
-
More Information
Article History
Received: 21 July 2024
Accepted: 7 February 2025
First Online: 17 March 2025
Competing interests
: S.A.B. is a cofounder and scientific advisor of Ona Therapeutics. G.S.H. is a scientific advisory board member of Crescenta Biosciences. J.S.T. is a founder and scientific advisory board member of Synchronicity Pharma. J.D.R. is a paid adviser and/or stockholder in Colorado Research Partners, L.E.A.F. Pharmaceuticals, Faeth Therapeutics and Empress Therapeutics; a paid consultant of Pfizer; a founder and stockholder in Marea Therapeutics; and a founder, director and stockholder of Farber Partners, Raze Therapeutics and Sofro Pharmaceuticals. S.K. serves as a scientific advisory board member of Moonwalk Biosciences. V.D.L. has equity interest in L-Nutra, a company making medical food, and has filed patents related to fasting-mimicking diets and their medical use. M.A.L. is on the advisory board of Pfizer and serves on the advisory board and is a cofounder of Flare Therapeutics. E.V. is a scientific cofounder of Napa Therapeutics and BHB Therapeutics and serves on the scientific advisory board of Seneque. J.A. is a board member of NOV Metapharma, a founder and/or consultant for Vandria and Amprenta Therapeutics and consults for OrsoBio, MetroBiotech and Amazentis (now Timeline); none of these companies develop products regulating circadian activity. D.J.D. has served as a consultant or speaker within the past 12 months for Amgen, AstraZeneca, Boehringer Ingelheim, Kallyope, Novo Nordisk and Pfizer. S.P. is the author of the books the Circadian Code and the Circadian Diabetes Code and is a scientific advisor to Hooke London, Avadel and WndrHlth. Other authors have no conflict of interests to declare.
